Advanced search
Publication Cover
Pharmacogenomics and Personalized Medicine Volume 7, 2014 - Issue
Submit an article Journal homepage
68
Views
13
CrossRef citations to date
0
Altmetric
Review

Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition

M William AudehDivision of Medical Oncology, Samuel Oschin Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USACorrespondence[email protected]
Pages 307-316 | Published online: 03 Oct 2014

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ahmed Kamal, Thokhir Basha Shaik & Mohammed Shaheer Malik. (2015) Embracing synthetic lethality of novel anticancer therapies. Expert Opinion on Drug Discovery 10:10, pages 1119-1132.
Read now

Articles from other publishers (12)

I Nyoman Bayu Mahendra & William Alexander Setiawan. (2022) PARP Inhibitor for Ovarian Cancer Therapy. European Journal of Medical and Health Sciences 4:6, pages 1-7.
Crossref
Thalita Basso Scandolara, Bruno Ricardo Barreto Pires, Beatriz Vacario, Isis Salviano Soares de Amorim, Priscyanne Barreto Siqueira, Juliana Mara Serpeloni, André Luiz Mencalha, Cibele Rodrigues Bonvicino & Carolina Panis. (2022) An Overview Regarding Pharmacogenomics and Biomarkers Discovery: Focus on Breast Cancer. Current Topics in Medicinal Chemistry 22:20, pages 1654-1673.
Crossref
Marina K. Ibragimova, Matvey M. Tsyganov & Nikolai V. Litviakov. (2021) Molecular-Genetic Portrait of Breast Cancer with Triple Negative Phenotype. Cancers 13:21, pages 5348.
Crossref
Sevide Sencan, Mine Tanriover, Mustafa Ulasli, Didem Karakas & Bulent Ozpolat. (2021) UV radiation resistance-associated gene (UVRAG) promotes cell proliferation, migration, invasion by regulating cyclin-dependent kinases (CDK) and integrin-β/Src signaling in breast cancer cells. Molecular and Cellular Biochemistry 476:5, pages 2075-2084.
Crossref
Vikram Thakur & Rajaletchumy Veloo Kutty. (2019) Recent advances in nanotheranostics for triple negative breast cancer treatment. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Soley Bayraktar & Adnan Aydiner. 2019. Breast Cancer. Breast Cancer 483 508 .
Gamze Guney Eskiler, Gulsah Cecener, Unal Egeli & Berrin Tunca. (2018) Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer. Pharmaceutical Research 35:11.
Crossref
Ana C. Gregório, Manuela Lacerda, Paulo Figueiredo, Sérgio Simões, Sérgio Dias & João Nuno Moreira. (2017) Therapeutic Implications of the Molecular and Immune Landscape of Triple-Negative Breast Cancer. Pathology & Oncology Research 24:4, pages 701-716.
Crossref
Bàrbara Roig, Marta Rodríguez-Balada, Sara Samino, Eric W.-F. Lam, Sandra Guaita-Esteruelas, Ana R. Gomes, Xavier Correig, Joan Borràs, Oscar Yanes & Josep Gumà. (2017) Metabolomics reveals novel blood plasma biomarkers associated to the BRCA1-mutated phenotype of human breast cancer. Scientific Reports 7:1.
Crossref
Henri Wathieu, Naiem T. Issa, Aileen I. Fernandez, Manisha Mohandoss, Deanna M. Tiek, Jennifer L. Franke, Stephen W. Byers, Rebecca B. Riggins & Sivanesan Dakshanamurthy. (2017) Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method. Oncotarget 8:54, pages 92926-92942.
Crossref
Davide Caruso, Anselmo Papa, Silverio Tomao, Patrizia Vici, Pierluigi Benedetti Panici & Federica Tomao. (2017) Niraparib in ovarian cancer: results to date and clinical potential. Therapeutic Advances in Medical Oncology 9:9, pages 579-588.
Crossref
Kyung-Hee Chun, Jong Hoon Park & Siting Fan. 2017. Translational Research in Breast Cancer. Translational Research in Breast Cancer 59 104 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.